ICON plc
The Clinical Trial Manager for Post Trial Access at ICON leads and coordinates project activities to ensure the timely, budgeted, and high-quality delivery of programs supporting patient access to investigational products prior to regulatory approval.
ICON plc is a global clinical research organisation (CRO) that provides outsourced clinical development and commercialisation services to pharmaceutical, biotechnology and medical device companies. It offers end-to-end drug and device development support — including clinical trial management across phases, data management and biostatistics, regulatory and safety/pharmacovigilance, and commercialisation and market-access services. ICON combines scientific and therapeutic expertise with technology and a scalable global operations network to accelerate development and bring therapies to patients. Clients engage ICON for integrated, experienced CRO support across the full product lifecycle.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ICON plc.
ICON plc didn’t post a salary, so this is our estimate from similar listings.
Post Trial Access Manager
IQVIA
Post-Trial Access Manager, Continued Access - Sponsor Dedicated
IQVIA
Expanded Access Manager / Post-Trial Access Specialist - FSP - UK
lifelancer
Senior Manager, Post Trial Supply
BeOne Medicines
Associate Director, Clinical Supply Chain Engineer
Sarepta Therapeutics
Senior Manager, Clinical Trial Supplies
Crinetics Pharmaceuticals